chartexchange

Q1 INTERIM REPORT JULY – SEPT 2026

Cision | Nov 13, 2026 3:00 AM EST

Cancer Therapy and Novel treatments of bacterial infections

“ We have reached major goals in the fields of Cancer Therapy and Novel Anti-infectives, two of the major   causes of disease. Our goal is to make the new therapies available to patients through suitable commercial   partnerships. Reaching Phase III studies has been a long-term goal and we are there. We also have a   strong pipeline of drug candidates in our portfolio to support the commercialization of innovations made   by scientists at Lund University into the clinic”, comments Catharina Svanborg, Chairman.

“ We have

Read original article